Gonzaga, Baby Girl .
HRN: 22-65-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
03/15/2023
03/22/2023
IV
7mg
Q24hr
Neonatal Asphyxia
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes